Related Articles
Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma
Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer
Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab
Synergistic antitumor effect of the anti‑ErbB2 antibodies trastuzumab and H2‑18 on trastuzumab‑resistant gastric cancer cells
Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer